Selective targeting and timing of matrix metalloproteinase inhibition in post-myocardial infarction remodeling

William M Yarbrough1, Rupak Mukherjee, G Patricia Escobar

  • 1Division of Cardiothoracic Surgery, Medical University of South Carolina, Charleston, and Procter and Gamble Pharmaceuticals, Mason, Ohio, USA.

Circulation
|September 17, 2003
PubMed
Abstract

Insights

Selective matrix metalloproteinase (MMP) inhibition, sparing MMP-1 and MMP-7, can favorably influence left ventricular (LV) remodeling after myocardial infarction (MI). The timing of this selective MMP inhibition (sMMPi) impacts remodeling patterns.

Area of Science:

  • Cardiovascular Research
  • Myocardial Infarction
  • Cardiac Remodeling

Background:

  • Matrix metalloproteinase (MMP) induction is linked to left ventricular (LV) remodeling post-myocardial infarction (MI).
  • The necessity of broad-spectrum MMP inhibition and optimal timing remain undetermined.
  • This study investigates MMP-1 and MMP-7-sparing inhibition (sMMPi) effects on LV remodeling.

Purpose of the Study:

  • To evaluate the impact of sMMPi on regional and global LV remodeling.
  • To determine if initiating sMMPi before or after MI alters remodeling outcomes.
  • To assess the necessity of inhibiting MMP-1 and MMP-7 for favorable LV remodeling.

Main Methods:

  • Pigs underwent myocardial infarction (MI) and were randomized to MI only, sMMPi initiated pre-MI, or sMMPi initiated post-MI.
  • Radiopaque markers tracked changes in the area at risk.
  • LV remodeling was assessed at 10 days post-MI via infarct size, LV end-diastolic volume, and collagen content.

Main Results:

  • Infarct size was similar across all MI groups.
  • sMMPi attenuated LV end-diastolic volume expansion compared to MI only.
  • Collagen content changes differed between pre-MI and post-MI sMMPi groups in infarct and remote zones.

Conclusions:

  • Inhibition of MMP-1 and MMP-7 is not essential for beneficial LV remodeling post-MI.
  • The timing of sMMPi initiation significantly influences regional and global myocardial remodeling patterns after MI.

Related Concept Videos

Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult body.
A...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...